Nurtec ODT (Rimegepant)

Rimegepant is a medicine used to treat migraines and to help prevent them. It is a tablet that melts on or under your tongue. It works by blocking a protein called CGRP that plays a big part in migraine pain.

Brand names:Nurtec ODT
Medication

What people taking Nurtec ODT (Rimegepant) report

Every report comes from a Lived member, sent anonymously.

Have you tried Nurtec ODT (Rimegepant) for Migraines?

NameHow it went

About Nurtec ODT (Rimegepant)

What It's For

Rimegepant, sold as Nurtec ODT, is a prescription migraine medicine with two approved uses in adults. Taken when a migraine strikes, it treats the attack, whether or not the migraine comes with aura (the visual or sensory changes some people notice before the headache). Taken on a regular every-other-day schedule, it helps prevent episodic migraine. Its preventive approval covers episodic migraine, not chronic migraine, and it is not approved for children or teenagers. Rimegepant belongs to a newer group of medicines called gepants, which target CGRP (calcitonin gene-related peptide), a signaling molecule central to migraine. Most older preventive medicines were developed for other conditions and later found to help migraine; gepants were designed for migraine itself. The American Headache Society considers CGRP-targeting treatments, including rimegepant, a first-line choice for prevention, meaning a person does not have to try and fail other preventive medicines first.

How It Works

CGRP is a natural signaling molecule in the nervous system, and research shows it plays a key role in causing migraine. Like other messengers, it acts by attaching to a specific receptor on cells. Rimegepant occupies that receptor and blocks CGRP from delivering its signal, which can ease an attack that is under way and, with regular dosing, make attacks less frequent. Exactly how this blockade produces the clinical benefit is not fully understood. The tablet is absorbed fairly quickly, reaching its highest level in the blood about an hour and a half after a dose, and it takes roughly 11 hours for the body to clear half of it.

Dosage & Administration

Nurtec ODT is a 75 mg orally disintegrating tablet (the ODT in its name). Placed on or under the tongue, it dissolves in saliva and is swallowed without water. It can be taken with or without food. For a migraine attack, one tablet is taken as needed. The limit is one tablet in 24 hours, and the safety of using more than 18 doses in a 30-day period has not been established, so frequent use is worth raising with the prescriber. For prevention, one tablet is taken every other day, whether or not a headache is present. The tablets are fragile. Open the blister pack with dry hands, peel back the foil rather than pushing the tablet through it, and put the tablet in your mouth right away. Do not take tablets out of the blister to carry or store for later.

Side Effects

Most people have few side effects. Nausea was the most common in the trial of attack treatment, affecting about 2 in 100 people compared with fewer than 1 in 100 on a placebo (dummy pill). With every-other-day use, nausea and stomach pain or indigestion each affected about 2 to 3 in 100 people. Allergic reactions are uncommon but can be serious, and they can appear days after a dose rather than right away. A rash, hives or itching after taking it is a reason to stop and contact the prescriber promptly. Trouble breathing or swelling of the lips, tongue or throat is an emergency: call 911. Since the medicine came to market, reports have linked it and similar drugs to two circulation problems. Blood pressure can rise, or existing high blood pressure can get worse, most often within the first week; some people needed blood pressure treatment or a hospital stay. Tell the prescriber if your readings go up. Raynaud's phenomenon, in which narrowed blood vessels make fingers or toes turn white or blue and feel cold or numb, can start or flare, usually within a couple of days of a dose. If that happens, stop rimegepant and contact your prescriber; in most reported cases the symptoms went away after the medicine was stopped.

Interactions & Warnings

Rimegepant should not be used by anyone who has had an allergic reaction to it before. The body breaks rimegepant down mainly through a liver enzyme called CYP3A4, so medicines that slow or speed up this enzyme change how much of the drug reaches the blood. Strong enzyme blockers, such as the antifungal itraconazole, raise rimegepant levels about fourfold and should not be combined with it. Medicines that speed the enzyme up, such as the tuberculosis antibiotic rifampin, can lower levels enough that rimegepant stops working, so these should be avoided too. With moderate CYP3A4 blockers, or with drugs that block a transport protein called P-gp (examples include the heart rhythm medicine amiodarone and cyclosporine, which is used after organ transplants), the advice is to avoid a second rimegepant dose within 48 hours. Many common prescriptions fall into these groups, so have a pharmacist check your full medication list. Rimegepant should be avoided by people with severe liver disease or end-stage kidney disease, including those on dialysis, because levels can build up or have not been studied. Mention high blood pressure or a history of Raynaud's phenomenon before starting, since either can worsen. There is not enough information on use during pregnancy to judge its safety, and a pregnancy registry is collecting outcomes, so discuss plans to become pregnant with the prescriber. A study of breastfeeding women found that very little rimegepant passes into breast milk, though effects on a nursing baby have not been studied.

What to Expect

Rimegepant helps many people but does not stop every attack. In the main trial, people took one tablet during a migraine of moderate to severe pain. Two hours later, about 21 in 100 were pain free compared with about 11 in 100 on placebo, and about 59 in 100 had their pain reduced to mild or none compared with about 43 in 100. More people were also back to normal activity at two hours, and fewer needed a rescue medicine later that day. About 14 in 100 stayed pain free from two hours through the next two days, compared with about 5 in 100 on placebo. Some people find a different treatment works better for them. Prevention works more gradually and is judged over months. In the prevention trial, people who started with about 10 migraine days a month had about 4.3 fewer per month after three months, compared with 3.5 fewer on placebo, so the medicine's added effect averaged about one migraine day a month. About half of those taking rimegepant had their moderate to severe migraine days cut at least in half, compared with about 4 in 10 on placebo. Individual responses vary widely, and keeping track of migraine days helps you and your prescriber decide whether it is worth continuing. People using it for prevention still need a plan for attacks that break through. Because blood pressure can rise, especially in the first week, checking it after starting is sensible, particularly for anyone who already has high blood pressure.

Questions to Ask Your Doctor

  1. 1.Should I use rimegepant only for attacks, for prevention, or both, and how would that plan work alongside my other migraine medicines?
  2. 2.How does rimegepant compare with a triptan or other options for someone with my health history?
  3. 3.Do any of my current medicines or supplements interact with rimegepant, and do I need to space doses around them?
  4. 4.How often should I check my blood pressure after starting, and what readings should prompt a call?
  5. 5.How will we decide after a few months whether it is helping enough to continue?

Last reviewed • Oct 2026

Educational content, not medical advice.